Pulmozyme
Term · Oncology and biomedicine · MLC-T-ONC-007090
A drug given in an aerosol mist to decrease the thickness of mucus in the lungs of patients with cystic fibrosis. It is also being studied as a treatment to reduce the thickness of saliva in patients being treated for head and neck cancer. Pulmozyme contains an enzyme that breaks the DNA in mucus into small pieces and makes the mucus thinner. Also called dornase alfa inhalation solution.
| Identifier | MLC-T-ONC-007090 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | dornase alfa inhalation solution |
| References | NCI Dictionary of Cancer Terms |
Record as JSON
{
"id": "MLC-T-ONC-007090",
"term": "Pulmozyme",
"field": "Oncology and biomedicine",
"definition": "A drug given in an aerosol mist to decrease the thickness of mucus in the lungs of patients with cystic fibrosis. It is also being studied as a treatment to reduce the thickness of saliva in patients being treated for head and neck cancer. Pulmozyme contains an enzyme that breaks the DNA in mucus into small pieces and makes the mucus thinner. Also called dornase alfa inhalation solution.",
"synonyms": [
"dornase alfa inhalation solution"
],
"references": [
"NCI Dictionary of Cancer Terms"
],
"url": "https://mlchart.com/terminology/oncology/pulmozyme/"
}
Record 13,871 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.